Cargando…

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients

INTRODUCTION: The purpose of this study was to assess the efficacy of the insulin tolerance test (ITT) in predicting the effectiveness of insulin sensitizers in type 2 diabetic patients. METHODS: We retrospectively reviewed 360 consecutive patients with type 2 diabetes admitted to Osaka University H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozawa, Junji, Iwahashi, Hiromi, Okita, Kohei, Okauchi, Yukiyoshi, Imagawa, Akihisa, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare Communications 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138481/ https://www.ncbi.nlm.nih.gov/pubmed/22127749 http://dx.doi.org/10.1007/s13300-010-0011-7

Ejemplares similares

Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
por: Okita, Kohei, et al.
Publicado: (2013)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance
por: Kozawa, Junji, et al.
Publicado: (2012)

Extent of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation and glycated hemoglobin of 5.6–6.4%
por: Iwahashi, Hiromi, et al.
Publicado: (2015)

Complete loss of insulin secretion capacity in type 1A diabetes patients during long‐term follow up
por: Uno, Sae, et al.
Publicado: (2017)

Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6–6.4%, with visceral fat accumulation, but not without visceral fat accumulation
por: Okauchi, Yukiyoshi, et al.
Publicado: (2013)

Case of a novel PAX6 mutation with aniridia and insulin‐dependent diabetes mellitus
por: Motoda, Saori, et al.
Publicado: (2018)

Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study
por: Okauchi, Yukiyoshi, et al.
Publicado: (2011)

Predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity
por: Akita, Etsuko F, et al.
Publicado: (2010)

Hyperinsulinemia and Insulin Receptor Gene Mutation in Nonobese Healthy Subjects in Japan
por: Fujita, Shingo, et al.
Publicado: (2017)

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
por: Inoue, Kana, et al.
Publicado: (2011)

Human pancreatic α‐ to β‐cell area ratio increases after type 2 diabetes onset
por: Fujita, Yukari, et al.
Publicado: (2018)

Glucose Intolerance After Pancreatectomy Was Associated With Preoperative Hemoglobin A1c, Insulin Resistance, and Histological Pancreatic Fatty Infiltration
por: Ishibashi, Chisaki, et al.
Publicado: (2018)

An Impaired Awareness of Hypoglycemia Improved After Vitamin B(12) Treatment in a Type 1 Diabetic Patient
por: Fujita, Shingo, et al.
Publicado: (2017)

Prader-Willi Syndrome with Slowly Progressive Insulin-dependent Diabetes Mellitus
por: Tomoda, Yuki, et al.
Publicado: (2020)

Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue
por: Baden, Megu Yamaguchi, et al.
Publicado: (2015)

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Diabetes due to Mitochondrial Adipopathy
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Type 2 diabetes mellitus prevention strategy: Target and goal in Japanese men
por: Iwahashi, Hiromi, et al.
Publicado: (2016)

Suppression Failure of Cortisol Secretion by Dexamethasone May Occur in Glucagon-like Peptide-1 Receptor Agonist-treated Patients with Diabetic Autonomic Neuropathy
por: Nagai, Yasuki, et al.
Publicado: (2018)

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity
por: Nagao, Hirofumi, et al.
Publicado: (2013)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy
por: Motoda, Saori, et al.
Publicado: (2018)

Characteristics of sleep–wake cycle and sleep duration in Japanese type 2 diabetes patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2017)

Pancreatic fat is related to the longitudinal decrease in the increment of C‐peptide in glucagon stimulation test in type 2 diabetes patients
por: Ishibashi, Chisaki, et al.
Publicado: (2019)

Pseudohypoglycemia or hyperglycemia caused by interference with self‐monitoring blood glucose measurements in anticancer ascorbic acid therapy
por: Kimura, Takekazu, et al.
Publicado: (2013)

Increased NKX6.1 expression and decreased ARX expression in alpha cells accompany reduced beta-cell volume in human subjects
por: Fujita, Yukari, et al.
Publicado: (2021)

Insulin‐producing cells derived from ‘induced pluripotent stem cells’ of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis‐related genes
por: Hosokawa, Yoshiya, et al.
Publicado: (2017)

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2015)

Whole-exome Sequencing Analysis of a Japanese Patient With Hyperinsulinemia and Liver Dysfunction
por: Fujita, Shingo, et al.
Publicado: (2022)

Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules
por: Horii, Tomomi, et al.
Publicado: (2022)

Clinical Significance of the Maximum Body Mass Index Before Onset of Type 2 Diabetes for Predicting Beta-Cell Function
por: Ozawa, Harutoshi, et al.
Publicado: (2020)

Maximum body mass index before onset of type 2 diabetes is independently associated with advanced diabetic complications
por: Ozawa, Harutoshi, et al.
Publicado: (2021)

Evaluation of Hypothalamic–Pituitary–Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test
por: Hayakawa, Tomoaki, et al.
Publicado: (2018)

Ectopic Fat Accumulation in Pancreas and Heart
por: Kozawa, Junji, et al.
Publicado: (2021)

Regional Variations of Insulin Secretion and Insulin Sensitivity in Japanese Participants With Normal Glucose Tolerance
por: Watanabe, Kiriko, et al.
Publicado: (2021)

Asymptomatic Pontine Lesion and Diabetic Amyotrophy after Rapid Improvement of Poor Glycemic Control in a Patient with Type 1 Diabetes
por: Shimizu, Yuri, et al.
Publicado: (2019)

Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross‐sectional study
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k4987pju7204tvj9at52retq4u